Copyright
©The Author(s) 2023.
World J Clin Cases. Nov 16, 2023; 11(32): 7770-7777
Published online Nov 16, 2023. doi: 10.12998/wjcc.v11.i32.7770
Published online Nov 16, 2023. doi: 10.12998/wjcc.v11.i32.7770
Table 1 Comparison of the general information patients in the two groups
| Group | Gender (Male/Female) | Age (yr) | BMI (kg/m2) | Type of lung infection (n) | |||
| Germ | Fungus | Mix | Others | ||||
| Therapy group (40) | 26/14 | 54.78 ± 3.09 | 25.01 ± 3.67 | 18 | 13 | 7 | 2 |
| Control group (40) | 27/13 | 54.62 ± 3.10 | 25.33 ± 3.65 | 20 | 14 | 3 | 3 |
| χ2/t | 0.056 | 0.231 | 0.391 | 0.201 | 0.056 | 1.829 | 0.213 |
| P value | 0.813 | 0.818 | 0.697 | 0.654 | 0.813 | 0.176 | 0.644 |
- Citation: Chen X, Dai L, Ma JZ, Chu XX, Dai L, Liu JM, Guo SW, Ru XW, Zhuang XS. Clinical study of NFNC in the treatment of acute exacerbation chronic obstructive pulmonary disease patients with respiratory failure. World J Clin Cases 2023; 11(32): 7770-7777
- URL: https://www.wjgnet.com/2307-8960/full/v11/i32/7770.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i32.7770